Amarin Reports Second Quarter 2020 Financial Results and Provides Update on Operations

NEXT STORY
CRISPR Technology Market to Grow by 20.91% in 2020, Accelerated by the Outbreak of COVID-19 – Industry Projections to 2030
PREV STORY
7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients with Ovarian Cancer

BEIJING, China and CAMBRIDGE, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News

RedHill Biopharma Reports Third Quarter 2018 Financial Results and Business Highlights

Key Highlights: Top-line results from the confirmatory Phase III study with TALICIA® for H. ...

author_avatar
NASDAQ Market News

TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week

PRESS RELEASE TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week ...

author_avatar
NASDAQ Market News